Adding a GLP-1 receptor agonist as a coadjutant therapy in the early post-transplant period to the appropriate patient brings good metabolic outcomes and also is safe, Mario Campana, MD, fellow in the division of endocrinology, diabetes and metabolism at the Heersink School of Medicine at the University of Alabama at Birmingham (UAB), told Healio
Mounjaro side effects Mounjaros use is accompanied by critical side effect warnings, including potential risks for: Thyroid tumours Pancreatitis Hypoglycemia Severe allergic reactions Kidney failure Gallbladder problems Mounjarois not suitable for individuals with a history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or those allergic to its ingredients
Understanding the science, limitations, and safety considerations is essential before considering supplementation
With B12, as with many nutrients, the goal is not as much as possible
Companies need cognitive reasoning and advanced analytics platforms that can automatically process the many thousands of possible scenarios and their implications at the speed of the market
